Compare, Analyse Novartis with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ADCOCK INGRAM (S. Africa) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   ADCOCK INGRAM
EQUITY SHARE DATA
    NOVARTIS
Mar-19
ADCOCK INGRAM
Jun-14
NOVARTIS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs980314-   
Low Rs600226-   
Sales per share (Unadj.) Rs198.793.4-  
Earnings per share (Unadj.) Rs21.0-23.5-  
Cash flow per share (Unadj.) Rs22.3-19.5-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.573.3-  
Shares outstanding (eoy) m24.69168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.02.9 137.4%   
Avg P/E ratio x37.7-11.5 -328.2%  
P/CF ratio (eoy) x35.5-13.9 -256.2%  
Price / Book Value ratio x2.63.7 69.7%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,50845,603 42.8%   
No. of employees `0000.64.3 13.5%   
Total wages/salary Rs m1,1712,862 40.9%   
Avg. sales/employee Rs Th8,445.43,671.4 230.0%   
Avg. wages/employee Rs Th2,015.7666.7 302.3%   
Avg. net profit/employee Rs Th891.0-925.1 -96.3%   
INCOME DATA
Net Sales Rs m4,90715,761 31.1%  
Other income Rs m783110 709.1%   
Total revenues Rs m5,68915,872 35.8%   
Gross profit Rs m123-2,731 -4.5%  
Depreciation Rs m32680 4.7%   
Interest Rs m16427 3.7%   
Profit before tax Rs m858-3,728 -23.0%   
Minority Interest Rs m0-10 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m340233 146.0%   
Profit after tax Rs m518-3,971 -13.0%  
Gross profit margin %2.5-17.3 -14.4%  
Effective tax rate %39.6-6.2 -634.4%   
Net profit margin %10.6-25.2 -41.9%  
BALANCE SHEET DATA
Current assets Rs m8,05511,544 69.8%   
Current liabilities Rs m1,8506,495 28.5%   
Net working cap to sales %126.432.0 394.7%  
Current ratio x4.41.8 244.9%  
Inventory Days Days45111 40.6%  
Debtors Days Days34124 27.4%  
Net fixed assets Rs m1506,729 2.2%   
Share capital Rs m12373 168.6%   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,59212,371 61.4%   
Long term debt Rs m04,347 0.0%   
Total assets Rs m9,82423,369 42.0%  
Interest coverage x54.9-7.7 -710.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.7 74.1%   
Return on assets %5.4-15.2 -35.8%  
Return on equity %6.8-32.1 -21.2%  
Return on capital %11.5-19.8 -58.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,9431,345 -144.4%  
From Investments Rs m2,742-413 -663.9%  
From Financial Activity Rs m-2983,945 -7.6%  
Net Cashflow Rs m5014,878 10.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.33 Rs / ZAR

Compare NOVARTIS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: SUN PHARMA  NATCO PHARMA  GSK PHARMA  STRIDES PHARMA SCIENCE  VENUS REMEDIES  



Today's Market

Sensex Ends 224 Points Higher; Realty and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended on a positive note.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

6 Charts Showing the State of Indian Financial Markets in 2020 (Sector Info)

May 26, 2020

Six charts showing how Indian financial markets have performed in 2020 so far...

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio (Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

What the RBI's Rate Cut Means for Options Traders (Fast Profits Daily)

May 25, 2020

The RBI governor has cut the repo rate to 4%. What does this mean for options traders? Find out in this video.

Which Stocks Should You Buy, Sell, and Hold in the Market Today? (Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NOVARTIS SHARE PRICE


May 29, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

OTHER USEFUL LINKS

MARKET STATS